Fallopian Tube Cancer Market - Size, Share, Outlook, and Forecast till 2026

Fallopian Tubes also called as uterine tube are pair of tubes, which carry an egg from the ovary to the uterus. Fallopian tube cancer also called as tubal cancer is caused due to uncontrolled growth of cells in fallopian tubes that connect the ovaries and the uterus. This is very rare type of cancer and it is characterized by symptoms such as abnormal vaginal bleeding, especially after menopause, abdominal pain or a feeling of pressure in the abdomen, abnormal vaginal discharge that is white, clear or pinkish, and pelvic mass at the time of diagnosis. Although fallopian tube cancer can occur at any age, it majorly affects women between the ages of 50 and 60, age. Also, it is more common in Caucasian women who had few or no children.

Increasing prevalence of gynecological and reproductive disorders such as breast cancer, endometrial cancer, cervical cancer, ovarian cancer, and vaginal cancer is key factor fueling growth of the fallopian tube cancer market. Previous research studies reported that women who have inherited the gene linked to breast and ovarian cancer, called BRCA1, are show an increased risk of developing fallopian tube cancer. According to the article published in the University of California San Francisco, fallopian tube cancer is rare and accounts for 2 percent of all gynecologic cancers. Around 1,500 to 2,000 cases of fallopian tube cancer have been reported worldwide. An estimated 300 to 400 women are diagnosed with the condition annually in the U.S.

Key Developments in Fallopian Tube Cancer Market

Market players are engaged in developing novel drugs for treatment of fallopian tube cancer in order to meet increasing demand from healthcare sector, which in turn is driving growth of the fallopian tube cancer market size. Furthermore, launch and novel drugs to treat the fallopian cancer and their approval by regulatory bodies is boosting growth of the fallopian tube cancer market. For instance, in June 2018, the Genentech, biotechnology company received Food and Drug Administration (FDA) approval for combination of Avastin (bevacizumab) plus the chemotherapy agents carboplatin and paclitaxel, followed by Avastin alone, for the treatment of patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer following initial surgical resection. Key players operating in fallopian tube cancer market include AbbVie Inc, Amgen Inc, Arrien Pharmaceuticals LLC, AstraZeneca Plc., Atara Biotherapeutics Inc, Bayer AG, BeiGene Ltd, Boehringer Ingelheim GmbH, Boston Biomedical Inc, Bristol-Myers Squibb Co, Caladrius Biosciences Inc, Celgene Corp, Celldex Therapeutics Inc, Dr. Reddy’s Laboratories Ltd, Eisai Co Ltd, Eli Lilly and Co, EpiThany Inc, Exelixis Inc, F. Hoffmann-La Roche Ltd among others.

Global Nasogastric Tube Market Outlook 2018-2023

Published Date : Sep 2018

Global nasogastric tube market is anticipated to grow at a CAGR of 6.87% by 2023, according to a new report published by Gen Consulting Company. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography (North America, Euro...

Global Composite Telescopic Tube Market Research Report 2018

Published Date : Sep 2018

Composite Telescopic Tube Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United Stat...

Global Flexible Fin Film Tube Market Research Report 2018

Published Date : Sep 2018

Flexible Fin Film Tube Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States,...

Global Ocular Cancer Drug Market Research Report 2018

Published Date : Sep 2018

Ocular Cancer Drug Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Ger...

Asia-Pacific Pitot Tube Anemometers Market Report 2017

Published Date : Oct 2017

In this report, the Asia-Pacific Pitot Tube Anemometers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sa...

Asia-Pacific Compact Fluorescent Tube Market Report 2017

Published Date : Oct 2017

In this report, the Asia-Pacific Compact Fluorescent Tube market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with ...

Asia-Pacific Cancer Antibody Drug Conjugates Market Report 2017

Published Date : Oct 2017

In this report, the Asia-Pacific Cancer Antibody Drug Conjugates market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions...

Asia-Pacific Breast Cancer Predictive Genetic Testing Market Report 2017

Published Date : Oct 2017

In this report, the Asia-Pacific Breast Cancer Predictive Genetic Testing market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several ke...

EMEA (Europe, Middle East and Africa) Colon Cancer Rapid Test Kit Market Report 2017

Published Date : Oct 2017

In this report, the EMEA Colon Cancer Rapid Test Kit market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, Wit...

EMEA (Europe, Middle East and Africa) Breast Cancer Screening Market Report 2017

Published Date : Oct 2017

In this report, the EMEA Breast Cancer Screening market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sa...

 

Select Licence :

  • Single User : $4500
  • Multiple User : $7000
  • Corporate User : $10000

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.